US Patent 11021515 Therapeutically active compounds and their methods of use
Patent 11021515 was granted and assigned to Agios Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+196 characters)
Article
Patent abstract
Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Dawei Cui0
Ding Zhou0
Janeta Popovici-Muller0
Jeremy Travins0
Rene M. Lemieux0
Zhenwei Cai0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110215150
Date of Patent
June 1, 2021
0Patent Application Number
168717770
Date Filed
May 11, 2020
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 11021515 Therapeutically active compounds and their methods of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11021515
Date of patent
June 1, 2021
Patent application number
16871777
Date Filed
May 11, 2020
Patent primary examiner
Find more entities like US Patent 11021515 Therapeutically active compounds and their methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.